- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04806165
Treatment Uptake Chatbot for Eating Disorders
September 18, 2023 updated by: Washington University School of Medicine
Developing an Optimized Conversational Agent or "Chatbot" to Facilitate Mental Health Services Use in Individuals With Eating Disorders
Eating disorders (EDs) are serious mental illnesses associated with high morbidity and mortality, clinical impairment, and comorbid psychopathology.
Although evidence-based treatments for EDs have been established, the treatment gap is wide.
Indeed, <20% of individuals with EDs receive treatment.
There is need for a novel solution not only to identify individuals with EDs but also to encourage mental health services use and to address treatment barriers.
This study aims to implement a conversational agent or "chatbot" that is optimized to increase mental health services use among individuals with EDs through such features as: 1) education on the seriousness and consequences of EDs; 2) engaging the user in motivational interviewing to overcome barriers to care; 3) providing a personalized recommendation for seeking intervention; 4) repeated check-ins with the user to encourage follow-up with care.
This study will utilize a randomized optimization trial with adults who have completed screening on the National Eating Disorders Association (NEDA) website and screen positive for an ED but are not in treatment to determine chatbot feasibility and to generate data on the effect of the chatbot on motivation for treatment and mental health services use.
This trial will employ the Multiphase Optimization Strategy framework, using a 2^4 full factorial design, to randomly assign participants to a combination of the four proposed intervention components (n=16 conditions) to isolate the active ingredients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
- Behavioral: Repeated Administration
- Behavioral: Personalized Recommendation
- Behavioral: Motivational Interviewing
- Behavioral: Core Modules Only
- Behavioral: Motivational Interviewing, Personalized Recommendation, Repeated Administration
- Behavioral: Motivational Interviewing, Repeated Administration
- Behavioral: Motivational Interviewing, Personalized Recommendation
- Behavioral: Personalized Recommendation, Repeated Administration
- Behavioral: Psychoeducation
- Behavioral: Psychoeducation, Repeated Administration
- Behavioral: Psychoeducation, Personalized Recommendation
- Behavioral: Psychoeducation, Motivational Interviewing
- Behavioral: Psychoeducation, Motivational Interviewing, Personalized Recommendation
- Behavioral: Psychoeducation, Personalized Recommendation, Repeated Administration
- Behavioral: Psychoeducation, Motivational Interviewing, Repeated Administration
- Behavioral: Psychoeducation, Motivational Interviewing, Personalized Recommendation, Repeated Administration
Study Type
Interventional
Enrollment (Actual)
205
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- U.S. resident
- English-speaking
- Age 18 years or older
- Owns a personal smartphone
- Screens positive for a Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) clinical or subclinical eating disorder
- Not currently receiving treatment for an eating disorder
Exclusion Criteria:
- Non-U.S. resident
- Younger than 18 years old
- Does not own a personal smartphone
- Does not screen positive for a DSM-5 clinical or subclinical eating disorder
- Screens positive for Avoidant Restrictive Food Intake Disorder
- Currently receiving treatment for an eating disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Motivational Interviewing
|
A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder.
|
Experimental: Repeated Administration
|
A discussion with the chatbot, including follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
|
Experimental: Personalized Recommendation
|
A discussion with the chatbot, including identifying a personalized recommendation for accessing help for their eating disorder.
|
Experimental: Core Modules Only
|
A discussion with the chatbot, including only the core modules.
|
Experimental: Motivational Interviewing, Personalized Recommendation, Repeated Administration
|
A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, identifying a personalized recommendation for accessing help for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
|
Experimental: Motivational Interviewing, Repeated Administration
|
A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
|
Experimental: Motivational Interviewing, Personalized Recommendation
|
A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder and identifying a personalized recommendation for accessing help for their eating disorder.
|
Experimental: Personalized Recommendation, Repeated Administration
|
A discussion with the chatbot, including identifying a personalized recommendation for accessing help for their eating disorder and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
|
Experimental: Psychoeducation
|
A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders.
|
Experimental: Psychoeducation, Repeated Administration
|
A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
|
Experimental: Psychoeducation, Personalized Recommendation
|
A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders and identifying a personalized recommendation for accessing help for their eating disorder.
|
Experimental: Psychoeducation, Motivational Interviewing
|
A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders and motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder.
|
Experimental: Psychoeducation, Motivational Interviewing, Personalized Recommendation
|
A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, and identifying a personalized recommendation for accessing help for their eating disorder.
|
Experimental: Psychoeducation, Personalized Recommendation, Repeated Administration
|
A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, identifying a personalized recommendation for accessing help for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
|
Experimental: Psychoeducation, Motivational Interviewing, Repeated Administration
|
A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
|
Experimental: Psychoeducation, Motivational Interviewing, Personalized Recommendation, Repeated Administration
|
A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, identifying a personalized recommendation for accessing help for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rates of Treatment/Services Utilization for Eating, Shape, or Weight Concerns Among All Participants Randomized to the Intervention Following Online Eating Disorder Screening
Time Frame: 2, 6, 14 Weeks from Engagement with the Intervention
|
Treatment utilization was measured at each follow-up time point (2, 6, and 14 weeks), which was assessed via the prompt, "Have you tried or used any type of mental health help (e.g., self-help app, telehealth/in-person counseling, etc.) for your concerns related to your eating, shape, or weight in the past [2, 6, or 14] weeks?".
We defined a participant as having utilized treatment at the first time they responded, "yes" (vs.
"no") to this question.
The data presented below indicate the rates of self-reported receipt of treatment/services utilization among participants assigned (component on) or not assigned (component off) to each of the four chatbot components (motivational interviewing, psychoeducation, personalized recommendations, repeated administration), as delineated by each time point during which the aforementioned item was assesed.
|
2, 6, 14 Weeks from Engagement with the Intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Willingness to Seek Psychotherapy
Time Frame: Baseline, 2 Weeks, 6 Weeks, 14 Weeks
|
Participants' willingness to seek psychotherapy was assessed via an identical item in the baseline assessment (i.e., before the initial chatbot assessment) as well as each off the follow-up assessments delivered at 2, 6, and 14 weeks post-intervention.
The item prompted users to rate their willingness to seek in-person or telehealth psychotherapy in subsequent weeks.
Responses were rated on a Likert scale from 1 (not at all important/ready) to 7 (very important/ready).
Mean values reported below indicate the average Likert scale willingness rating among all participants at each time point who did (component turned on) and did not (component turned off).
Statistical analyses outline the time and component effects on changes in mean willingness to seek pyschotherapy from baseline to 14 weeks post-interventioon.
|
Baseline, 2 Weeks, 6 Weeks, 14 Weeks
|
Mean Attitude Toward Change for Concerns Related to Eating, Shape, or Weight Concerns Among All Participants Randomized to the Intervention Following Online Eating Disorder Screening
Time Frame: Baseline, 2 weeks, 6 weeks, 14 weeks
|
Participants' attitudes toward making changes (i.e., motivation toward seeking help) to address their personal eating, shape, and weight concerns were measured via identical items in the baseline assessment, and in each of the 2, 6, and 14 week follow-up assessments.
Items included, "How important is it for you to change your eating, shape, or weight concerns?"
and, "How ready are you to make changes in your eating, shape, or weight concerns?".
Both items were rated on a Likert scale from 1 (not at all important/ready) to 7 (very important/ready), and the sum of the two questions was used as an index of change/motivation attitudes.
Values below indicate the average Likert scale attitude rating (from 2 (lowest) to 14 (highest)) among all participants at each time point who did (component turned on) and did not (component turned off) receive each component.
Analyses outline the time, component, and time by component interaction effects on changes in motivation attitudes since baseline.
|
Baseline, 2 weeks, 6 weeks, 14 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Ellen E Fitzsimmons-Craft, PhD, Washington University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 9, 2021
Primary Completion (Actual)
March 9, 2022
Study Completion (Actual)
May 9, 2022
Study Registration Dates
First Submitted
March 11, 2021
First Submitted That Met QC Criteria
March 17, 2021
First Posted (Actual)
March 19, 2021
Study Record Updates
Last Update Posted (Actual)
October 11, 2023
Last Update Submitted That Met QC Criteria
September 18, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202007008
- K08MH120341 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eating Disorders
-
Bezmialem Vakif UniversityMuğla Sıtkı Koçman University; The Scientific and Technological Research Council... and other collaboratorsActive, not recruitingEating Disorders | Eating Behavior | Orthodontic Appliance Complication | Eating HabitTurkey
-
Shalvata Mental Health CenterUniversity of Haifa; The Touro College and University SystemUnknownBinge-Eating Disorder | Bulimia Nervosa | Night-eating Syndrome
-
Stanford UniversityNational Institute of Mental Health (NIMH)RecruitingEating DisorderUnited States
-
Cornell CollegeNational Institute of Mental Health (NIMH)Completed
-
McMaster UniversityCompletedEating DisorderCanada
-
Washington University School of MedicineCompletedEating Disorder
-
Laval UniversityCanadian Foundation for Dietetic Research (CFDR)Completed
-
Lindner Center of HOPEUniversity of CincinnatiCompleted
-
University of North Carolina, Chapel HillThe Hilda & Preston Davis Foundation; Global Foundation for Eating DisordersCompletedEating Disorder | Binge-eating DisorderUnited States
-
Stanford UniversityCompletedBinge Eating | Purging (Eating Disorders)United States
Clinical Trials on Repeated Administration
-
University of Applied Sciences and Arts of Southern...Completed
-
Rambam Health Care CampusCompleted
-
University of Colorado, DenverTemple University; Vitamix FoundationRecruiting
-
Faculdade de Motricidade HumanaCentro de Alto Rendimento do JamorNot yet recruitingHypoventilation | Normoxia | Normobaric HypoxiaPortugal
-
Faculdade de Motricidade HumanaUniversity of Sao Paulo; Coordenação de Aperfeiçoamento de Pessoal de Nível...RecruitingHypoventilation | Normoxia | Normobaric HypoxiaPortugal
-
Tartu University HospitalCompletedPeripheral Arterial DiseaseEstonia
-
State University of New York - Upstate Medical...Reflex Sympathetic Dystrophy Syndrome Association (RSDSA)RecruitingComplex Regional Pain Syndrome Type IUnited States
-
University of Illinois at ChicagoNational Institute on Aging (NIA)Completed
-
University of PrimorskaCompletedOccupational ExposureSlovenia
-
Hvidovre University HospitalCompletedHamstring Injury | Sprint PerformanceDenmark